Media

September 21, 2017

QuiremSpheres® will be reimbursed in Belgium as of 1 October 2017

We are happy to announce that QuiremSpheres® will be fully reimbursed in Belgium as of 1 October 2017.

Jan Sigger, CEO of Quirem Medical B.V., the manufacturer of QuiremSpheres®, said: “The decision of the Belgian authorities to fully reimburse QuiremSpheres® is consistent with the fact that our product uses the same mode of action and the same radiotherapeutic principles to target liver cancer as existing products on the market. Additionally, we believe that usage of QuiremSpheres® can further enhance treatment outcome by the unique possibility to visualize and quantify the intrahepatic dose distribution right after the SIRT procedure.”

More information can be found on the website of our strategic partner Terumo, which is the exclusive global distributor of QuiremSpheres®.